Anemia biomarkers and mortality in hemodialysis patients with or without diabetes: A 10-year follow-up study.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2023
2023
Historique:
received:
26
08
2022
accepted:
10
01
2023
entrez:
31
1
2023
pubmed:
1
2
2023
medline:
3
2
2023
Statut:
epublish
Résumé
Many studies have assessed the association between anemia and mortality in hemodialysis but few compared patients with and without diabetes. Our study aims to investigate the impact of hemoglobin and iron parameters on mortality in hemodialysis patients with or without diabetes. This is a two-center retrospective study that included all adult patients who started hemodialysis between February 2012 and February 2020, followed until January 2021. Averages of hemoglobin, ferritin and transferrin saturation of entire follow-up were recorded. Kaplan Meier survival, log rank test and cox regression analyses were performed to assess the association between anemia biomarkers and mortality. A total of 214 patients were included. Mean age was 67.98 ±12.41 years, mean hemoglobin was 10.92 ±0.75 g/dL, mean ferritin was 504.43 ± 221.42 ng/mL and mean transferrin saturation was 26.23 ±7.77%. Log rank test showed an association between hemoglobin ≥11 g/dL and better survival in patients without diabetes (P = 0.028). Based on cox regression analysis, hemoglobin was associated with all-cause mortality in all patients (HR = 0.66; CI:0.49,0.89; P = 0.007). When comparing patients with and without diabetes, this association remained significant only in patients without diabetes (HR = 0.53; CI:0.37,0.77; P<0.001). Based on different multivariate models, hemoglobin, ferritin and age were independent factors associated with mortality in patients without diabetes. This study showed that hemoglobin ≥11 g/dL is associated with better survival in hemodialysis patients without diabetes but not in those with diabetes. These differences need to be further explored in other countries and settings. An individualization of the hemoglobin target level might be necessary to improve patients' outcomes.
Sections du résumé
BACKGROUND
Many studies have assessed the association between anemia and mortality in hemodialysis but few compared patients with and without diabetes. Our study aims to investigate the impact of hemoglobin and iron parameters on mortality in hemodialysis patients with or without diabetes.
METHODS
This is a two-center retrospective study that included all adult patients who started hemodialysis between February 2012 and February 2020, followed until January 2021. Averages of hemoglobin, ferritin and transferrin saturation of entire follow-up were recorded. Kaplan Meier survival, log rank test and cox regression analyses were performed to assess the association between anemia biomarkers and mortality.
RESULTS
A total of 214 patients were included. Mean age was 67.98 ±12.41 years, mean hemoglobin was 10.92 ±0.75 g/dL, mean ferritin was 504.43 ± 221.42 ng/mL and mean transferrin saturation was 26.23 ±7.77%. Log rank test showed an association between hemoglobin ≥11 g/dL and better survival in patients without diabetes (P = 0.028). Based on cox regression analysis, hemoglobin was associated with all-cause mortality in all patients (HR = 0.66; CI:0.49,0.89; P = 0.007). When comparing patients with and without diabetes, this association remained significant only in patients without diabetes (HR = 0.53; CI:0.37,0.77; P<0.001). Based on different multivariate models, hemoglobin, ferritin and age were independent factors associated with mortality in patients without diabetes.
CONCLUSIONS
This study showed that hemoglobin ≥11 g/dL is associated with better survival in hemodialysis patients without diabetes but not in those with diabetes. These differences need to be further explored in other countries and settings. An individualization of the hemoglobin target level might be necessary to improve patients' outcomes.
Identifiants
pubmed: 36719878
doi: 10.1371/journal.pone.0280871
pii: PONE-D-22-23532
pmc: PMC9888689
doi:
Substances chimiques
Transferrin
0
Ferritins
9007-73-2
Hemoglobins
0
Biomarkers
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0280871Informations de copyright
Copyright: © 2023 Asmar et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
BMC Nephrol. 2019 Mar 5;20(1):81
pubmed: 30836953
J Am Soc Nephrol. 2006 Apr;17(4):1181-91
pubmed: 16565261
Nephron Clin Pract. 2012;120(2):c91-c100
pubmed: 22377677
J Am Soc Nephrol. 2010 Nov;21(11):1970-8
pubmed: 20947632
Nephrol Dial Transplant. 2010 Sep;25(9):2846-50
pubmed: 20591813
N Engl J Med. 1993 Sep 30;329(14):1001-6
pubmed: 8366899
Nephrol Dial Transplant. 2018 Dec 1;33(12):2234-2244
pubmed: 30010940
Nephrol Dial Transplant. 2004 Jan;19(1):121-32
pubmed: 14671047
Kidney Int. 2003 May;63(5):1908-14
pubmed: 12675871
J Am Soc Nephrol. 2021 Aug;32(8):2020-2030
pubmed: 34244326
J Am Soc Nephrol. 1999 Mar;10(3):610-9
pubmed: 10073612
J Am Soc Nephrol. 2004 Aug;15(8):2208-18
pubmed: 15284307
Kidney Int. 2015 Jan;87(1):162-8
pubmed: 25075769
Clin J Am Soc Nephrol. 2008 May;3(3):777-82
pubmed: 18337553
Blood Purif. 2004;22(1):175-80
pubmed: 14732826
Am J Kidney Dis. 1998 Jun;31(6):997-1006
pubmed: 9631845
Am J Kidney Dis. 2006 Jan;47(1):24-36
pubmed: 16377382
J Nephrol. 2017 Dec;30(6):821-829
pubmed: 27644959
N Engl J Med. 2019 Jan 31;380(5):447-458
pubmed: 30365356
J Nephrol. 2021 Jun;34(3):781-790
pubmed: 33555578
Nephrol Dial Transplant. 2017 Apr 1;32(suppl_2):ii121-ii128
pubmed: 28201666
Kidney Int. 2021 Jun;99(6):1280-1295
pubmed: 33839163
Hemodial Int. 2008 Oct;12(4):450-62
pubmed: 19090868
J Ren Nutr. 2009 Mar;19(2):127-35
pubmed: 19218039
Am J Kidney Dis. 2011 Feb;57(2):255-65
pubmed: 20801571
Nephrol Dial Transplant. 2019 May 1;34(5):848-858
pubmed: 30202988
Ther Apher Dial. 2014 Oct;18(5):404-13
pubmed: 24571446
Nephron. 1982;31(2):103-10
pubmed: 7121651
Nephrology (Carlton). 2019 Dec;24(12):1265-1272
pubmed: 30644618
J Am Heart Assoc. 2018 Aug 7;7(15):e009206
pubmed: 30371224
Kidney Int. 2006 Jul;70(2):351-7
pubmed: 16738536
Clin J Am Soc Nephrol. 2014 Nov 7;9(11):1930-9
pubmed: 25318751
Lancet. 2013 Jul 20;382(9888):260-72
pubmed: 23727169
Kidney Int. 2014 Oct;86(4):845-54
pubmed: 24759150
J Am Soc Nephrol. 2007 Dec;18(12):3164-70
pubmed: 18003781
Am J Kidney Dis. 1996 Jul;28(1):53-61
pubmed: 8712222
Nephrol Dial Transplant. 2014 Dec;29(12):2316-26
pubmed: 25150218
Clin J Am Soc Nephrol. 2006 Nov;1(6):1205-10
pubmed: 17699349
Nat Rev Nephrol. 2022 Jun;18(6):378-395
pubmed: 35194215